Isolated Lymphangiomatous Polyp Nasopharynx in an Adult First Case Report in English Literature

Abstract

Lymphangiomas are rare benign, hamartomatous, congenital malformations of the lymphatic system involving the skin and subcutaneous tissues of head, neck and oral cavity. Occasional adult onset cases occur, this condition is thought to be a developmental malformation of lymph vessels which have poor communication with normal lymph system. Most of these malformations are present at birth or appear within two years of life. 75 % of cases occur in head and neck area, submandibular and parotid being the most affected parts. Lymphangioma arising in nasopharynx and in an adult has not been reported in english literature. This prompted us to report the very first case of Lymphangioma Nasopharynx.

A Rare Cause of Snoring: Isolated Nasopharyngeal Lymphangioma

“…These tumors are seen most often in the head and neck region and more rarely may be observed in the axilla and abdomen. As isolated nasopharyngeal lymphangiomas are extremely rare, few cases have been reported in the literature since the first case in 1966 [1,2]. In the light of information in literature, we present the case of a 40-year-old patient diagnosed with isolated nasopharyngeal lymphangioma, who underwent surgery and had no complaints during a 1-year follow-up period.…”

Cervical Lymphangiomas in Children: Non-Surgical Treatment with Focus on Sclerotherapy. Literature Review

“…dysphagia, dyspnoea) malformations would require non-conservative treatment; this implies a multidisciplinary approach (surgical, radiological, physician's) which varies according to each patient's characteristics and lesions, considering the lack of univocal indications for treatment as well as all those issues related to the young age of the patient (psychological or parental concern). Traditional surgical treatment has been considered for many years the gold standard for lymphatic malformations and is still considered the most definitive solution; however, as lymphangiomas are infiltrative, a complete eradication is often impossible [5]. This explains the relatively high percentage of recurrences (up to 27%) and intraoperative risks, with a mortality rate of 2-6%.…”